Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism
Nils Mülling, … , Benjamin Wilde, Ramon Arens
Nils Mülling, … , Benjamin Wilde, Ramon Arens
Published July 2, 2024
Citation Information: J Clin Invest. 2024;134(17):e179561. https://doi.org/10.1172/JCI179561.
View: Text | PDF
Research Article Immunology

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism

  • Text
  • PDF
Abstract

Cytomegalovirus (CMV) is one of the most common and relevant opportunistic pathogens in people who are immunocompromised, such as kidney transplant recipients (KTRs). The exact mechanisms underlying the disability of cytotoxic T cells to provide sufficient protection against CMV in people who are immunosuppressed have not been identified yet. Here, we performed in-depth metabolic profiling of CMV-specific CD8+ T cells in patients who are immunocompromised and show the development of metabolic dysregulation at the transcriptional, protein, and functional level of CMV-specific CD8+ T cells in KTRs with noncontrolled CMV infection. These dysregulations comprise impaired glycolysis and increased mitochondrial stress, which is associated with an intensified expression of the nicotinamide adenine dinucleotide nucleotidase (NADase) CD38. Inhibiting NADase activity of CD38 reinvigorated the metabolism and improved cytokine production of CMV-specific CD8+ T cells. These findings were corroborated in a mouse model of CMV infection under conditions of immunosuppression. Thus, dysregulated metabolic states of CD8+ T cells could be targeted by inhibiting CD38 to reverse hyporesponsiveness in individuals who fail to control chronic viral infection.

Authors

Nils Mülling, Felix M. Behr, Graham A. Heieis, Kristina Boss, Suzanne van Duikeren, Floortje J. van Haften, Iris N. Pardieck, Esmé T.I. van der Gracht, Ward Vleeshouwers, Tetje C. van der Sluis, J. Fréderique de Graaf, Dominique M.B. Veerkamp, Kees L.M.C. Franken, Xin Lei, Lukas van de Sand, Sjoerd H. van der Burg, Marij J.P. Welters, Sebastiaan Heidt, Wesley Huisman, Simon P. Jochems, Martin Giera, Oliver Witzke, Aiko P.J. de Vries, Andreas Kribben, Bart Everts, Benjamin Wilde, Ramon Arens

×

Figure 1

Frequency and phenotype of CMV-specific CD8+ T cells are unaffected by loss of viral control while cytokine production is decreased.

Options: View larger image (or click on image) Download as PowerPoint
Frequency and phenotype of CMV-specific CD8+ T cells are unaffected by l...
(A) Graphical overview of main study groups. Created with biorender.com. (B–G) PBMCs of HCs (n = 13), controllers (n = 22), and noncontrollers (n = 14) were analyzed ex vivo. (B) Representative plots of pp65495–503 and spike269–277–specific CD8+ T cells in the same host. (C) Frequencies of pp65495–503 and spike269–277–specific CD8+ T cells of total CD8+ T cells. (D) UMAP analysis (left) and FlowSOM consensus metaclustering with 5 clusters (right) was performed on pp65495–503–specific CD8+ T cells (downsampled to equal numbers between groups). (E) Expression intensity of cell surface markers. (F) Hierarchically clustered heatmap of phenotypes of the 5 clusters shown in D. Marker expression per cluster as z score of median signal intensity per channel. (G) Cluster frequencies of pp65495–503–specific CD8+ T cells. (H) Percentage IFN-γ+CD137+ (left) and IFN-γ+TNF+IL-2+CD137+ cells (right) of pp65495–503–specific CD8+ T cells stimulated for 20 hours with peptide (n = 4–7/group). Data are presented as mean ± SEM or as boxplot. Bounds of the boxes indicate upper and lower quartile, lines indicate median, whiskers indicate min and max. Each dot represents an individual. Statistical analysis by 1-way ANOVA with Tukey’s test for multiple comparisons or 2-way ANOVA with Šidák’s test for multiple comparisons. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts